Hoth Therapeutics Stock Alpha and Beta Analysis

HOTH Stock  USD 1.26  0.02  1.56%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hoth Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hoth Therapeutics over a specified time horizon. Remember, high Hoth Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hoth Therapeutics' market risk premium analysis include:
Beta
(1.95)
Alpha
2.06
Risk
23.56
Sharpe Ratio
0.0831
Expected Return
1.96
Please note that although Hoth Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Hoth Therapeutics did 2.06  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Hoth Therapeutics stock's relative risk over its benchmark. Hoth Therapeutics has a beta of 1.95  . As returns on the market increase, returns on owning Hoth Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Hoth Therapeutics is expected to outperform it. As of now, Hoth Therapeutics' Enterprise Value Multiple is increasing as compared to previous years.

Enterprise Value

(4.73 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Hoth Therapeutics Backtesting, Hoth Therapeutics Valuation, Hoth Therapeutics Correlation, Hoth Therapeutics Hype Analysis, Hoth Therapeutics Volatility, Hoth Therapeutics History and analyze Hoth Therapeutics Performance.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Hoth Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hoth Therapeutics market risk premium is the additional return an investor will receive from holding Hoth Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hoth Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hoth Therapeutics' performance over market.
α2.06   β-1.95

Hoth Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Hoth Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Hoth Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Hoth Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Hoth Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hoth Therapeutics shares will generate the highest return on investment. By understating and applying Hoth Therapeutics stock market price indicators, traders can identify Hoth Therapeutics position entry and exit signals to maximize returns.

Hoth Therapeutics Return and Market Media

The median price of Hoth Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 is 0.85 with a coefficient of variation of 33.82. The daily time series for the period is distributed with a sample standard deviation of 0.34, arithmetic mean of 1.01, and mean deviation of 0.26. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Hoth Therapeutics faces Nasdaq delisting over stock price - Investing.com
11/01/2024
2
Hoth Therapeutics Posts Quarterly Earnings Results, Misses Expectations By 0.01 EPS
11/15/2024
3
Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3
11/27/2024
4
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
12/20/2024
5
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday
01/07/2025
6
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries
01/08/2025
7
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
01/14/2025
8
Hoth Therapeutics, Inc. Short Interest Up 117.4 percent in December
01/16/2025
9
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
01/24/2025

About Hoth Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hoth or other stocks. Alpha measures the amount that position in Hoth Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
PB Ratio0.640.61
Capex To Depreciation184.64175.4

Hoth Therapeutics Upcoming Company Events

As portrayed in its financial statements, the presentation of Hoth Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hoth Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Hoth Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Hoth Therapeutics. Please utilize our Beneish M Score to check the likelihood of Hoth Therapeutics' management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Hoth Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out Hoth Therapeutics Backtesting, Hoth Therapeutics Valuation, Hoth Therapeutics Correlation, Hoth Therapeutics Hype Analysis, Hoth Therapeutics Volatility, Hoth Therapeutics History and analyze Hoth Therapeutics Performance.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Hoth Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Hoth Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hoth Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...